Search details
1.
Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial Cells.
Int J Mol Sci
; 24(4)2023 Feb 07.
Article
in English
| MEDLINE | ID: mdl-36834705
2.
Skin toxicity of enfortumab vedotin: Proposal of a specific management algorithm.
J Eur Acad Dermatol Venereol
; 38(1): e99-e101, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37607297
3.
A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZA.
Eur Urol
; 85(3): 274-282, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37271630
4.
Genomic Prostate Score: A New Tool to Assess Prognosis and Optimize Radiation Therapy Volumes and ADT in Intermediate-Risk Prostate Cancer.
Cancers (Basel)
; 15(3)2023 Feb 02.
Article
in English
| MEDLINE | ID: mdl-36765902
5.
Effect of Serelys Homme on the Incidence and Severity of Vasomotor Symptoms and Quality-of-Life Impairments in Patients Receiving Hormone Therapy and Radiation for Localized Prostate Cancer: Results of the ESCULAPE Phase 2 Prospective Study.
Adv Radiat Oncol
; 8(5): 101255, 2023.
Article
in English
| MEDLINE | ID: mdl-37408674
6.
Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study.
Eur J Cancer
; 193: 113292, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37717282
7.
Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status.
Eur J Cancer
; 180: 21-29, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36527973
8.
Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer: The CABASTY Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 9(12): 1629-1638, 2023 Dec 01.
Article
in English
| MEDLINE | ID: mdl-37883073
9.
Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study.
Cancers (Basel)
; 14(7)2022 Mar 25.
Article
in English
| MEDLINE | ID: mdl-35406448
10.
Chemotherapy following immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma.
Eur J Cancer
; 175: 43-53, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36088671
11.
Proviral role of human respiratory epithelial cell-derived small extracellular vesicles in SARS-CoV-2 infection.
J Extracell Vesicles
; 11(10): e12269, 2022 10.
Article
in English
| MEDLINE | ID: mdl-36271885
12.
Extracellular Vesicles in Advanced Prostate Cancer: Tools to Predict and Thwart Therapeutic Resistance.
Cancers (Basel)
; 13(15)2021 Jul 28.
Article
in English
| MEDLINE | ID: mdl-34359692
13.
Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data.
Cancer Treat Rev
; 97: 102191, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-34015728
14.
Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Génitales).
Eur J Cancer
; 158: 1-11, 2021 Oct 04.
Article
in English
| MEDLINE | ID: mdl-34619467
15.
Response to systemic therapy in fumarate hydratase-deficient renal cell carcinoma.
Eur J Cancer
; 151: 106-114, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33975058
16.
Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial.
Clin Genitourin Cancer
; 19(6): 554-562, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34602349
17.
Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study.
Eur J Cancer
; 136: 76-83, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32653774
18.
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study.
Eur J Cancer
; 80: 55-62, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28549248
19.
First-line antiangiogenics for metastatic renal cell carcinoma: A systematic review and network meta-analysis.
Crit Rev Oncol Hematol
; 107: 44-53, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-27823651
20.
Acute tubular necrosis after selective FGFR tyrosine kinase inhibitor therapy.
Eur J Cancer
; 139: 177-180, 2020 11.
Article
in English
| MEDLINE | ID: mdl-33011621
Results
1 -
20
de 20
1
Next >
>>